Patents/Assignees

Hiroshima Institute Of Life Sciences

1 patent in portfolio

US12497461utility2025
Human Ntcp-binding Antibody Capable of Inhibiting Infection of Hepatitis B Virus (HBV) to Human Hepatocytes
0 cites